Evaluation of the cost per patient per injection of botulinum toxin A in upper limb spasticity: comparison of two preparations in 19 countries
Stéphane Roze,1 Hannah Kurth,2 Barnaby Hunt,3 William Valentine,3 Rémi Marty11HEVA, Lyon, France; 2Ipsen Pharma, Boulogne-Billancourt, France; 3Ossian Health Economics and Communications, Basel, SwitzerlandBackground: Botulinum toxin A injections are indicated for the m...
Guardado en:
Autores principales: | Valentine W, Hunt B, Kurth H, Roze S, Marty R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/851a9fb9d1504871a27f3a92ca10f9fc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Decision-tree model for health economic comparison of two long-acting somatostatin receptor ligand devices in France, Germany, and the UK
por: Marty R, et al.
Publicado: (2012) -
Preparation and characterization of gelatin sponge millispheres injectable through microcatheters
por: Noboru Yamashita, et al.
Publicado: (2009) -
Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance
por: Berteau C, et al.
Publicado: (2015) -
Impact of the shape of the implantable ports on their efficiency of flow (injection and flushing)
por: Guiffant G, et al.
Publicado: (2014) -
Evaluation of long-acting somatostatin analog injection devices by nurses: a quantitative study
por: Adelman DT, et al.
Publicado: (2012)